Lori Westendorf

SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML

May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey et al. · Blood · 2013 · 381 citations

Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment

Charlotte F. McDonagh, Eileen Turcott, Lori Westendorf et al. · Protein Engineering Design and Selection · 2006 · 236 citations · Full text

Medicinal Chemistry, Parental Antibody-drug Conjugates, Medicine +15

Development of orally active inhibitors of protein and cellular fucosylation

Nicole M. Okeley, Stephen C. Alley, Martha E. Anderson et al. · Proceedings of the National Academy of Sciences · 2013 · 183 citations · Full text

Vitro Fucosylation, Glycobiology, Immunology +21

SGN–LIV1A: A Novel Antibody–Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer

Django Sussman, Leia M. Smith, Martha E. Anderson et al. · Molecular Cancer Therapeutics · 2014 · 128 citations

Metastatic Breast Cancer, Breast Oncology, Drug Targeting +11

Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index

Charlotte F. McDonagh, Kristine M. Kim, Eileen Turcott et al. · Molecular Cancer Therapeutics · 2008 · 96 citations